Efficacy of transvaginal mesh release surgery as a treatment option for complications after mid-urethral sling surgery
Dr Hyeon Woo Kim (1), Dr Dong GIl Shin (1), Dr Chul Soo Yoon (2), Dr Seong Choi (3), Dr Won Yeol Cho (4), Dr Kweon Sik Min (5), Dr Tae Hee Oh (6), Dr Wan Lee (7), Dr Si Kyun Park (1), Dr Jeong Zoo Lee (1)
(1) Pusan National University Hospital, Busan, South Korea, (2) BHS Han-seo Hospital, Busan, South Korea, (3) Kosin University College of Medicine, Busan, South Korea, (4) Dong-A University Hospital, Busan, South Korea, (5) Inje University Busan Paik Hospital, Busan, South Korea, (6) Samsung Changwon Hospital, Changwon , South Korea, (7) Ulsan-Jeil Hospital, Ulsan, South Korea
This study aims to evaluate the efficacy of transvaginal mesh release for managing complications after mid-urethral sling surgery.
Thirty-two patients who had undergone mid-urethral sling surgery underwent transvaginal mesh release due to postoperative complications. The medical records were retrospectively analyzed to evaluate the reasons for performing mesh release, preoperative and postoperative clinical features, and the postoperative changes of voiding function.
The reasons for transvaginal mesh release were voiding difficulty (n =10), severe urgency (n = 6), urge incontinence (n = 3), mucosal erosion (n = 4), labial abscess (n = 1), voiding difficulty + urge incontinence (n = 1), voiding difficulty + mucosal erosion (n = 2), and urge incontinence + mucosal erosion (n = 1). The mean postoperative voiding volume was 269.42 ± 131.01 mL and the postvoid residual urine was 59.24 ± 49.31 mL. Although the postoperative symptomatic improvement was seen in 28 patients, urinary incontinence recurrence and persistent severe urgency were seen in 1 and 3 patients, respectively.
Transvaginal mesh release surgery is an easy and effective procedure to manage the complications occurred by mid-urethral sling surgery.